This specific 1-29 sequence is often referred to as the "functional fragment" because it contains the essential binding domain required to activate GHRH receptors in the pituitary gland.

In the sophisticated world of endocrinology and molecular biology, few compounds have sparked as much curiosity as CJC-1295 DAC. As a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), this ...

We revealed that brain peptides activate GH–IGF-1 axis to prevent the progression of the early stages of MASLD pathology. Nagayama, I., et al. (2023). Complementary role of peripheral and central ...

Sermorelin, a synthetic analog of growth hormone–releasing hormone (GHRH 1–29), has long attracted scientific interest due to ...

Since its discovery over 50 years ago, the biological aspects of insulin-like growth factor-1 (IGF-1) have been determined to be extensive. Ranging from cell proliferation, cell differentiation and ...

Bowery Clinic today announced expanded, physician-led protocols centered on two clinically studied peptides that act upstream ...